Avidity Partners Management LP Intellia Therapeutics, Inc. Transaction History

Avidity Partners Management LP

$1.63 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $3.4 Million - $4.63 Million	170,000 New	170,000 $3.8 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $1.58 Million - $2.21 Million	68,334 Added 18.03%	447,434 $13.6 Million
Q3 2023 Nov 14, 2023	SELL	$31.62 - $45.78 $529,793 - $767,043	-16,755 Reduced 4.23%	379,100 $12 Million
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $731,194 - $973,304	-21,145 Reduced 5.07%	395,855 $16.1 Million
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $7.37 Million - $9.91 Million	-221,200 Reduced 34.66%	417,000 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$33.21 - $62.69 $12 Million - $22.6 Million	-360,900 Reduced 36.12%	638,200 $22.3 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $6.8 Million - $9.04 Million	-126,094 Reduced 11.21%	999,100 $55.9 Million
Q2 2022 Aug 15, 2022	BUY	$38.49 - $76.21 $28.3 Million - $56 Million	735,119 Added 188.46%	1,125,194 $58.2 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $22.7 Million - $46.4 Million	390,075 New	390,075 $28.3 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $25.3 Million - $34.7 Million	-251,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$132.37 - $176.78 $17.1 Million - $22.8 Million	-129,000 Reduced 33.95%	251,000 $33.7 Million
Q2 2021 Aug 16, 2021	BUY	$60.88 - $161.91 $23.1 Million - $61.5 Million	380,000 New	380,000 $61.5 Million
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $14.1 Million - $25.4 Million	-303,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $5.71 Million - $19.2 Million	303,000 New	303,000 $16.5 Million
Q3 2020 Nov 16, 2020	SELL	$17.47 - $24.93 $7.31 Million - $10.4 Million	-418,178 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.14 - $22.87 $4.66 Million - $9.56 Million	418,178 New	418,178 $8.79 Million

Others Institutions Holding NTLA

# of Institutions

314

Shares Held

91.5M

Call Options Held

442K

Put Options Held

880K

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

12.3M
Shares

$149 Million
2.39% of portfolio
Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$117 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$117 Million
0.0% of portfolio
State Street Corp Boston, MA

5.14M
Shares

$62.6 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.95M
Shares

$60.3 Million
3.75% of portfolio

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account